On June 13, 2025, Changsha Sinocare Inc. officially passed the rigorous audit by the internationally recognized certification body SGS (Société Générale de Surveillance) and successfully obtained the ISO/IEC 27001:2022 Information Security Management System certification (Certificate No.: CN25/00004046). This certification signifies that Sinocare’s information security management system complies with the stringent standards set by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC)—a strong testament to the company's advanced capabilities in managing information security at an international level.
Certified Scope Covers Core Business Areas of Sinocare:
-R&D Data Protection: Safeguarding sensitive information throughout the innovation and development processes.
-Data Privacy & Security: Ensuring strict confidentiality and protection of users’ personal health information.
-Supply Chain Information Risk Management: Implementing effective risk control for vendors and partners involved in information security.
The acquisition of ISO/IEC 27001 certification is authoritative recognition of the effectiveness of Sinocare’s current information security practices. It demonstrates that the company’s digital health services for diabetes and chronic disease management are now supported by a stronger security foundation, further enhancing user trust in the safety and reliability of its products and services.
Information security is a cornerstone of a trustworthy digital health ecosystem. Sinocare emphasized its ongoing commitment to investing in information security management, fully embedding ISO/IEC 27001 standards into its daily operations and product development processes. With advanced technologies and robust safeguards, Sinocare is empowering global users with more convenient and secure chronic disease management solutions.